ع
The World Health Organization reported this week that the Ebola outbreak in the Democratic Republic of the Congo is accelerating faster than response efforts can contain it. Director-General Tedros Adhanom Ghebreyesus told reporters on August 12 that at its current pace the 2026 epidemic would eclipse the 2014-2016 West African outbreak which killed more than 11,000 people. A WHO assessment found the virus gained a three-month head start before the official declaration on May 15 with initial cases misdiagnosed as malaria or typhoid according to regional health officials.
World Health Organization figures released at the end of July showed 3,605 confirmed cases and 1,587 deaths in the Democratic Republic of the Congo for a case fatality ratio of 44 percent. Subsequent tallies compiled by national authorities and shared with international partners placed the totals near 4,470 cases and 2,063 deaths by August 12 including limited cross-border infections in Uganda. The current outbreak has already become the largest ever recorded in the Democratic Republic of the Congo surpassing the 2018-2020 epidemic that registered 3,317 confirmed cases according to a WHO disease outbreak update.
The rare Bundibugyo species responsible has caused only two known prior outbreaks in 2007 and 2012 and lacks any approved vaccine or therapeutic drug a WHO briefing noted. Ongoing armed conflict and instability in eastern provinces have restricted health workers to reaching roughly 30 percent of identified cases according to WHO Africa regional director Dr Mohamed Janabi. Janabi stated at a news conference in Bunia that responders remain behind the virus adding that the outbreak began in February and spread undetected for months.
Clinical trials for potential countermeasures have begun to address the therapeutic gap. The UK’s Medicines and Healthcare products Regulatory Agency has authorised the first human trials of a Bundibugyo vaccine developed by University of Oxford researchers using technology similar to the Oxford-AstraZeneca COVID-19 shot. The World Health Organization is separately sponsoring a clinical trial inside the Democratic Republic of the Congo to test whether two existing antiviral therapies can improve survival rates among patients.
UNICEF has mobilised teams to safeguard children and families in affected communities where the virus has strained fragile health systems. The agency reported that makeshift Ebola treatment centres have displaced routine nutrition and vaccination services in hard-hit zones. Cross-border movement between the Democratic Republic of the Congo and Uganda has complicated containment with Ugandan authorities confirming at least two deaths linked to cases originating in the outbreak zone according to CDC situational reports.
Health officials continue to emphasise contact tracing isolation and safe burial practices while urging communities to report symptoms promptly. The World Health Organization has set a target of reversing transmission trends within three months though officials clarified this would mean bringing the outbreak under control rather than declaring it over. Tedros described the situation as one in which the virus maintains a significant lead forcing responders to play catch-up across a region already burdened by conflict and other endemic diseases.
